Nuwellis receives new U.S. patent for pediatric extracorporeal therapy safety design, enhancing IP portfolio.
The recent issuance of a patent has bolstered the pediatric intellectual property portfolio, enhancing their system-level safety design. This reinforces their position as a leading innovator in the field. The patent covers a range of establishments, including hospitals, clinics, and academic institutions. With this addition, the portfolio now comprises a total of 25 patents, boosting their intellectual property assets. This achievement underscores their commitment to advancing pediatric care and safety measures.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments